SCHEMBL4815074

SCHEMBL4815074

BrCC(CBr)=C(CBr)CBr

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.39
TRPA1 O75762 1/20 0.36
HSD17B10 Q99714 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9654916 0.71 HSD17B10 (0.31) TSHRHSD17B10TDP1
SCHEMBL4078581 0.62
SCHEMBL391556 0.62
SCHEMBL8655263 0.59
SCHEMBL8655256 0.59
SCHEMBL2166320 0.59
SCHEMBL2545247 0.59
SCHEMBL473764 0.59
SCHEMBL9633341 0.59
SCHEMBL160013 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114349610-B Synthesis method of hexabenzocoronene dimer containing bis [6] helical structure 上海师范大学 2024-03-26 CN claimed
CN-114349610-A Synthetic method of hexabenzocoronene dimer containing double [6] helical structure 上海师范大学 2022-04-15 CN claimed
US-5164477-A Preparation of polyoxazolines Kobayashi, Shiro (JP) 1992-11-17 US claimed
US-3968094-A Photodegradable plastics containing haloolefins THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF AGRICULTURE (US) 1976-07-06 US claimed
CN-111196806-B Guanidine derivative and application thereof 广东东阳光药业股份有限公司 2024-04-26 CN disclosed
CN-114349610-B Synthesis method of hexabenzocoronene dimer containing bis [6] helical structure 上海师范大学 2024-03-26 CN disclosed
CN-114349610-B Synthesis method of hexabenzocoronene dimer containing bis [6] helical structure 上海师范大学 2024-03-26 CN disclosed
WO-2024028795-A1 HETEROBICYCLIC COMPOUNDS AS ORAL GLP1R AGONISTS ZYDUS LIFESCIENCES LIMITED (IN) 2024-02-08 WO disclosed
CN-115382402-B Preparation method of composite membrane material 天津工业大学 2024-02-02 CN disclosed
US-20230065368-A1 INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X FORMA THERAPEUTICS, INC. 2023-03-02 US disclosed
CN-115382402-A Preparation method of composite membrane material 天津工业大学 2022-11-25 CN disclosed
EP-3868416-B1 INJECTABLE MACROPOROUS HYDROGELS ETH ZUERICH (CH) 2022-08-10 EP disclosed
US-6106594-A Method for separating methane from natural gas using bisglycoluril derivatives MOBIL OIL CORPORATION (US) 2000-08-22 US disclosed
WO-2000043101-A1 A METHOD FOR SEPARATING METHANE FROM NATURAL GAS USING BISGLYCOLURIL DERIVATIVES MOBIL OIL CORPORATION (US) 2000-07-27 WO disclosed
US-5091384-A ANTI-BACTERIAL QUINOLONE- AND NAPHTHYRIDONE-CARBOXYLIC ACID COMPOUNDS KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1992-02-25 US disclosed
US-5089621-A Intermediates for cephalosporins or quinolone derivative antibiotics KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1992-02-18 US disclosed
EP-0424851-A1 Quinolone compounds and a process for their preparation KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1991-05-02 EP disclosed
EP-0424852-A1 Diazabicycloamine compounds and a process for their preparation KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1991-05-02 EP disclosed
EP-0424850-A1 Quinolone compounds and a process for their preparation KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 1991-05-02 EP disclosed
US-3968094-A Photodegradable plastics containing haloolefins THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF AGRICULTURE (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230065368-A1 INHIBITING UBIQUITIN SPECIFIC PEPTIDASE 9X USP9X, USP19, USP39 TSHR 4189/4885TRPA1 4874/4885HSD17B10 2547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.